Request Appointment
353 East 68th StreetNew York, NY 10065
Overview of Dr. Rathkopf
Dr. Dana Rathkopf is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and New York-Presbyterian Hospital. She received her medical degree from Tulane University School of Medicine and has been in practice 28 years. Dr. Rathkopf accepts several types of health insurance, listed below. She is one of 527 doctors at Memorial Sloan Kettering Cancer Center and one of 397 doctors at New York-Presbyterian Hospital who specialize in Oncology. She has more than 100 publications and over 500 citings.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2002 - 2005
NYU Grossman School of MedicineResidency, Internal Medicine, 1998 - 2002
Tulane University School of MedicineClass of 1998
Certifications & Licensure
FL State Medical License 2021 - Present
CT State Medical License 2023 - 2027
NJ State Medical License 2021 - 2027
NY State Medical License 2000 - 2027
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2016-2017
- CMS Meaningful Use Stage 1 Certification MyMSK, Memorial Sloan Kettering, 2016-2017
Clinical Trials
- Docetaxel With Rapid Hormonal Cycling As A Treatment For Patients With Prostate Cancer Start of enrollment: 2003 Jul 01
- Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer Start of enrollment: 2003 Jul 01
- Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer Start of enrollment: 2009 Oct 01
Publications & Presentations
PubMed
- Apalutamide + Abiraterone Acetate plus Prednisone + Leuprolide with Stereotactic, Ultra-Hypofractionated Radiation in Very High-Risk Prostate Cancer: A Single-Arm, Pha...Sean M McBride, Daniel E Spratt, Marisa Kollmeier, Wassim Abida, Han Xiao
Clinical Cancer Research. 2026-05-01 - Genomic Features and Response to Poly(ADP-ribose) Polymerase Inhibition in Metastatic Castration-Resistant Prostate Cancer.Jeffery C W Chang, Subhiksha Nandakumar, Konrad H Stopsack, Christopher Fong, Karl Pichotta
JCO Precision Oncology. 2026-03-01 - FORMULA-509: A Multicenter Randomized Trial of Postprostatectomy Salvage Radiotherapy and 6 months of a GNRH Agonist with Either Bicalutamide or Abiraterone Acetate pl...Paul L Nguyen, Marisa A Kollmeier, Dana E Rathkopf, Karen E Hoffman, Amado J Zurita
European Urology. 2026-02-10
Lectures
- An open label phase 1/2A study to evaluate the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of TRC253, an androgen receptor antagonist, in pati...2019 ASCO Annual Meeting - 6/1/2019
- c15-160: Enzalutamide (ENZA) plus CC-115 in men with metastatic castration-resistant prostate cancer (mCRPC): A phase 1b Prostate Cancer Clinical Trials Consortium study.2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Press Mentions
New SU2C Teams Accelerate Clinical Trials for Difficult Breast & Prostate CancersSeptember 16th, 2019
Prostate Cancer Clinical Trial: What to ExpectJune 9th, 2016
ASCO GU 2020: Treatment Selection in CSPC: Considerations Now and Downstream in an Evolving Therapeutic Landscape (Discussion of Abstracts 82 and 162)February 16th, 2020
Insurance Accepted
- Aetna Choice POS II
BCBS Blue Card PPO
BCBS Illinois PPO
BCBS Minnesota Blue Cross Accord
BCBS New Mexico PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
First Health PPO
Great West PPO
Humana ChoiceCare Network PPOLovelace Health Plan PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
Presbyterian Commercial
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
WEA Trust Preferred Provider Plan - Trust Pref - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
